Please login to the form below

Not currently logged in
Email:
Password:

Almirall launches story campaign to raise rosacea awareness

The Red Girl highlights the negative psychological effects of the disease

Shared Skin

Almirall has launched a new story-based campaign to raise awareness of chronic dermatological disease rosacea in the US.

The Barcelona-based pharmaceutical company’s The Red Girl tells a tale of an embarrassed woman sending an apologetic email to her date.

As the story develops the woman explains she felt embarrassed that her condition flared up during their date, prompting her to leave without warning.

Although the cause is still unknown, rosacea affects around 16 million people in the US alone and is found to be more common in women than men.

The condition can cause redness and pimples typically on the face and neck. Additionally, flare-ups can worsen over time and the skin may adopt a roughened, orange peel texture.

As a ‘less well known disease’, Almirall aims to expose the negative psychological effects rosacea has on an individual by launching The Red Girl as part of its Derma Stories and #SharedSkin initiative.

The #SharedSkin campaign features 5 Almirall employees – one of which appears to have the symptoms of rosacea – with fake skin conditions to show the social impact of living with a dermatological disease.

Almirall said rosacea has “profound effects on a person’s psychological health” and due to its “highly visible nature it takes a particularly heavy toll on patients as there is no cure”.

After acquiring Poli Group in 2015, Almirall obtained a dermatology focused R&D structure including its rosacea brand.

Rosacea has also held a strong focus with various other pharmaceutical companies, among them Omega Pharma and Galderma, and work by both was highlighted at the 2015 Communiqué Awards.

Article by
Gemma Jones

30th March 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....